Ligand Pharmaceuticals Inc banner

Intrinsic Value

The intrinsic value of Ligand Pharmaceuticals Inc (LGDN) under the Base Case is EUR per share. Compared with the current market price of 280 EUR, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

LGDN Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when LGDN is below its intrinsic value
Today Hidden ·
LGDN Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to LGDN

Fundamental Analysis

What Ligand Pharmaceuticals Does

Pharmaceuticals Health Care

Ligand Pharmaceuticals is a biotech company that makes money mainly by licensing drug-development technologies to other drugmakers. It does not sell drugs directly to patients. Instead, it helps pharmaceutical and biotech partners create and improve medicines through tools such as formulation know-how and protein-based discovery platforms, then earns fees, milestones, and royalties tied to those partnered products.

Headquarters
United States of America US
Employees
47
IPO date
Nov 18, 1992
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Ligand Pharmaceuticals insiders are selling more than usual

Insider trading · Last trade on Nov 4, 2026

Sold $17.9m 8 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.

Continue LGDN Research

Decided on Ligand Pharmaceuticals? Get an email when LGDN reaches the price you’d buy at. Free with an account.

Other Ligand Pharmaceuticals listings

What is the Intrinsic Value of one LGDN stock?

The intrinsic value for Ligand Pharmaceuticals Inc (LGDN) under the Base Case is EUR.

Is LGDN stock undervalued or overvalued?

Compared with the current market price of 280 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top